Published Studies
Synopsis Nicotinamide phosphoribosyltransferase (NAMPT) helps produce NAD+, which is essential for mitochondrial function and energy balance in skeletal muscle cells. Using gene techniques to redu...
Read moreNicotinamide Riboside Protects Against Alcohol-Induced Fatty Liver: Preclinical Findings
Synopsis Scientists have discovered that blocking a key enzyme that consumes cellular energy may help protect the liver from alcohol-related damage. The enzyme, called poly(ADP-ribose) polymerase ...
Read moreAge-Related Changes in NAD Metabolome and Nicotinamide Riboside Levels: Preclinical Findings
Synopsis Nicotinamide adenine dinucleotide (NAD+) is an important molecule that helps cells produce energy and control gene activity. NAD+ levels naturally decline with age, and giving animals NAD...
Read moreNicotinamide Riboside Improves Alzheimer's Features and DNA Repair: Preclinical Findings
Synopsis Alzheimer’s disease (AD) involves problems with energy metabolism and DNA repair, but how these contribute to key AD features is unclear. A DNA repair-deficient AD mouse model (3xTgAD/Pol...
Read moreNicotinamide Riboside Protects Heart Function in Dilated Cardiomyopathy: Preclinical Findings
Synopsis In chronic heart failure, the heart’s energy metabolism is severely impaired. NAD+ is a key molecule that helps cells produce energy and respond to stress, making it an important focus in...
Read moreSynopsis Alzheimer’s disease (AD) is a devastating neurodegenerative disorder driven by the accumulation of toxic amyloid-β (Aβ) protein aggregates. This study identifies a conserved mitochondrial...
Read moreNicotinamide Riboside Restores Mitochondrial Function in Rev1-Deficient Cells: Preclinical Findings
Synopsis DNA, which carries the genetic information of all organisms, is constantly exposed to damage from both internal and external sources. If this damage—like single- or double-strand breaks—i...
Read moreNicotinamide Riboside Protects Against Liver Toxicity: Preclinical Findings
Synopsis This study looked at the role of the mitochondrial enzyme MNADK, which makes NADP from NAD+, in liver health. Mice lacking MNADK had higher levels of certain amino acids and carnitines, a...
Read moreNicotinamide Riboside Protects Neurons More Effectively Than NAD+: Preclinical Findings
Synopsis Loss of NAD+ is common in neurodegenerative diseases. Excitotoxicity, caused by excessive stimulation of neurons, leads to nerve damage. This study found that nicotinamide riboside (NR), ...
Read moreSynopsis Purple sweet potato color (PSPC), a natural compound from purple sweet potatoes, can help protect the liver from damage caused by a high-fat diet. In mice fed a high-fat diet, PSPC reduce...
Read moreNicotinamide Riboside Kinases Mediate NMN and NR Metabolism in Muscle Cells: Preclinical Findings
Synopsis Increasing NAD+ levels may help protect muscles from age-related decline. This study examined how skeletal muscle cells make NAD+ from precursors nicotinamide mononucleotide (NMN) and nic...
Read moreNAD+ Replenishment Prevents Thymus Atrophy and Liver Fat Accumulation: Preclinical Findings
Synopsis Dioxin (TCDD) is a highly toxic chemical that causes serious health problems like wasting, liver fat buildup, and thymus shrinkage in animals. Its toxic effects happen when it activates a...
Read moreSynopsis Damage to sensory nerves can cause peripheral neuropathy after chemotherapy. Increasing levels of nicotinamide adenine dinucleotide (NAD+) can protect nerves from injury. This study teste...
Read moreNicotinamide Riboside Decreased DNA Damage in Liver Cells: Preclinical Findings
Synopsis Hepatocellular carcinoma (HCC) is a fast-growing liver cancer, but its exact origin has been unclear. Using human data and mouse models, researchers found that HCC starts mainly from live...
Read moreNAD+ Biosynthesis Enzyme Protects Aortic Smooth Muscle Cells: Preclinical Findings
Synopsis The walls of the aorta weaken with age and stress, risking serious damage. Smooth muscle cells (SMCs) in the aorta need NAD+, made by the enzyme NAMPT, for health. In humans with aortic d...
Read moreSARM1 Enzyme Drives Axonal NAD+ Loss and Degeneration: Preclinical Findings
Synopsis Axonal degeneration, or the breakdown of nerve fibers, happens early in many neurological diseases. The protein SARM1 is a key driver of this process, causing axons to lose NAD+, a vital ...
Read moreAltered NAD+ and Glutathione Metabolism in Fatty Liver Disease: Preclinical Findings
SynopsisIn patients with non-alcoholic fatty liver disease (NAFLD), researchers identified altered liver metabolism, specifically increased demand for NAD+ and glutathione (GSH), a key antioxidant....
Read moreNicotinamide Riboside Dose Improves Metabolic Flexibility: Preclinical Findings
SynopsisMetabolic flexibility—the ability to switch between burning carbs and fats—is a marker of metabolic health. To study NR's effect on this, mice on a mildly obese diet received varying NR dos...
Read moreNicotinamide Riboside Enhances Liver Regeneration: Preclinical Findings
SynopsisThe regenerative capacity of the liver is essential for recovery from surgical resection or injuries induced by trauma or toxins. During liver regeneration, the concentration of nicotinamid...
Read moreNicotinamide Riboside Improves Muscle Function in Duchenne Muscular Dystrophy: Preclinical Findings
Synopsis Neuromuscular diseases such as Duchenne muscular dystrophy (DMD) arise from genetic mutations that cause progressive muscle weakness and degeneration. This study identifies nicotinamide a...
Read more